Reckitt Cuts Full-Year Outlook After Lysol Disruption Hits North American Sales
Reckitt Benckiser cut its outlook after a disruption in Lysol manufacturing slumped North American sales. It now anticipates 3.5% to 4.5% like-for-like growth.
By Aimee LookReckitt Benckiser cut its outlook for the year, as sales slumped in North America due to a disruption in Lysol manufacturing.The British consumer-goods giant, which makes Lysol cleaning spray and Mucinex cough medicine, said Tuesday that it anticipates 3.5% to 4.5% like-for-like growth…